Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey

Show simple item record Neffen, Hugo Mello, Joao F. Sole, Dirceu Naspitz, Charles K. [UNIFESP] Eduardo Dodero, Alberto Leon Garza, Hector Novelo Guerra, Edgard Baez-Loyola, Carlos Boyle, John M. Wingertzahn, Mark A. 2016-01-24T13:59:40Z 2016-01-24T13:59:40Z 2010-05-01
dc.identifier.citation Allergy and Asthma Proceedings. Providence: Ocean Side Publications Inc, v. 31, n. 3, p. S9-S27, 2010.
dc.identifier.issn 1088-5412
dc.description.abstract Allergies in Latin America is the first cross-national survey that describes the symptoms, impact, and treatment of nasal allergies (NAs) in individuals >= 4 years old in Latin America (LA). in total, 22,012 households across the Latin American countries of Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, and Venezuela were screened for children, adolescents, and adults with a diagnosis of NA and either symptoms or treatment in the past 12 months. A total of 1088 adults and 457 children and adolescents were included and the sample was probability based to ensure valid statistical inference to the population. Approximately 7% of the LA population was diagnosed with NAs with two of three respondents stating that their allergies were seasonal or intermittent in nature. A general practice physician or otolaryngologist diagnosed the majority of individuals surveyed. Nasal congestion was the most common and bothersome symptom of NAs. Sufferers indicated that their symptoms affected productivity and sleep and had a negative impact on quality of life. Two-thirds of patients reported taking some type of medication for their NAs, with a roughly equal percentage of patients reporting taking over-the-counter versus prescription medications. Changing medications was most commonly done in those reporting inadequate efficacy. the most common reasons cited for dissatisfaction with current medications were related to inadequate effectiveness, effectiveness wearing off with chronic use, failure to provide 24-hour relief, and bothersome side effects (e.g., unpleasant taste and retrograde drainage into the esophagus). Findings from this cross-national survey on NAs have confirmed a high prevalence of physician-diagnosed NAs and a considerable negative impact on daily quality of life and work productivity as well as substantial disease management challenges in LA. Through identification of disease impact on the LA population and further defining treatment gaps, clinicians in LA may better understand and treat NAs, thus leading to improvements in overall patient satisfaction and quality of life. (Allergy Asthma Proc 31:S9-S27, 2010; doi: 10.2500/aap.2010.31.3347) en
dc.description.sponsorship Nycomed
dc.format.extent S9-S27
dc.language.iso eng
dc.publisher Ocean Side Publications Inc
dc.relation.ispartof Allergy and Asthma Proceedings
dc.rights Acesso restrito
dc.subject Allergic rhinitis en
dc.subject efficacy en
dc.subject intranasal corticosteroids en
dc.subject nasal allergies en
dc.subject nasal allergy medications en
dc.subject productivity en
dc.subject quality of life en
dc.subject safety en
dc.subject sleep en
dc.subject survey en
dc.title Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey en
dc.type Artigo
dc.contributor.institution Childrens Hosp Orlando Alassia
dc.contributor.institution Universidade de São Paulo (USP)
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.contributor.institution Univ Buenos Aires
dc.contributor.institution Univ Autonoma Mexico
dc.contributor.institution Mexican Assoc Resp Care
dc.contributor.institution Hosp Angeles de las Lomas
dc.contributor.institution Univ Nacl Autonoma Mexico
dc.contributor.institution Schulman Ronca & Bucuvalas Inc
dc.contributor.institution Nycomed GmbH
dc.description.affiliation Childrens Hosp Orlando Alassia, Resp Med Unit, Santa Fe, Argentina
dc.description.affiliation Univ São Paulo, Dept Otorhinolaryngol, Sch Med, BR-05508 São Paulo, Brazil
dc.description.affiliation Universidade Federal de São Paulo, Dept Pediat, Div Allergy, São Paulo, Brazil
dc.description.affiliation Univ Buenos Aires, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina
dc.description.affiliation Univ Autonoma Mexico, Mexico City, DF, Mexico
dc.description.affiliation Mexican Assoc Resp Care, Mexico City, DF, Mexico
dc.description.affiliation Hosp Angeles de las Lomas, Dept Otorhinolaryngol, Dept Otorhinolaryngol Head & Neck Surg, Mexico City, DF, Mexico
dc.description.affiliation Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico
dc.description.affiliation Schulman Ronca & Bucuvalas Inc, New York, NY USA
dc.description.affiliation Nycomed GmbH, Florham Pk, NJ USA
dc.description.affiliationUnifesp Universidade Federal de São Paulo, Dept Pediat, Div Allergy, São Paulo, Brazil
dc.identifier.doi 10.2500/aap.2010.31.3347
dc.description.source Web of Science
dc.identifier.wos WOS:000279416800003


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record




My Account